We are witnessing the first reduction in life expectancy for young American adults since the 1960s as a result of overdoses and suicides. This chilling trend has left a lasting impact on our families, communities, and economy. According to a 2017 National Safety Council survey, 70% of employers reported their business had been affected by ...
We applaud both the House of Representatives and the Senate for drafting and passing the SUPPORT for Patients and Communities Act, designed to curb a growing national opioid crisis, which claimed more than 70,000 American lives last year. As a front-lines provider of evidence-based behavioral health services, we at Centerstone see the vast opportunities this ...
The U.S. Senate is now scheduled to vote on the Opioid Crisis Response Act of 2018 on Monday, September 17. Upon anticipated passage, leaders in the House and Senate are expected to quickly reconcile differences between the two chambers’ bills. While the existing legislation represents critical steps in addressing the opioid and drug epidemic that ...
Last month, Centerstone’s Legislative Advocacy team shared the anticipated timeline of a Senate vote on their version of an opioid package, noting it could come anywhere between July and December, 2018. They are now hearing that the Senate could vote on their version of an opioid package starting sometime next week. The team wants to offer ...
We applaud the U.S. House of Representatives for their critical work in passing the Opioid Prevention and Patient Safety Act (OPPS Act). This legislation will allow health care providers to practice truly integrated care – a key factor in our nation’s fight against the opioid epidemic. The OPPS Act will update an antiquated regulation – ...
On Wednesday, June 20, the Opioid Prevention and Patient Safety Act (OPPS Act) (H.R.6082) will go to the House floor for a full House vote. Centerstone has encouraged you to reach out to your representatives to make your support for the OPPS Act known and today, the final push is on. This is your last chance to ...
Wednesday, June 20, the U.S. House of Representatives is slated to vote on the Opioid Prevention and Patient Safety Act (OPPS Act) (H.R. 6082), critical legislation in our nation’s fight against the opioid epidemic. We encourage our legislators to support this bill to ensure that health care providers have the information they need to accurately ...
Last week, dozens of bills produced by the House of Representatives became Centerstone’s top priorities. Among them, the Opioid Prevention and Patient Safety Act (OPPS Act) (H.R.5795) is the most controversial and hotly contested among lawmakers and stakeholders. The OPPS Act passed the House Energy & Commerce Committee last week, and will be up for ...
Centerstone has opened a new office at 440 1st Street NW, Suite 430, Washington, DC 20002 for the Legislative Advocacy staff. Centerstone’s space is housed within the larger office of Horizon Government Affairs (parent company of coalition groups Health IT Now and the Opioid Safety Alliance, of which Centerstone is a part) as well as ...
David Guth recently testified before the House Subcommittee on Health’s “Combating the Opioid Crisis: Improving the Ability of Medicare and Medicaid to Provide Care For Patients,” a series of hearings to uncover solutions to growing opioid abuse across the U.S. David participated in one of the final sessions of the hearings: a panel of five behavioral health ...
